[{"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA087702"], "brand_name": ["DEXAMETHASONE SODIUM PHOSPHATE"], "generic_name": ["DEXAMETHASONE SODIUM PHOSPHATE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0641-0367", "0641-6145", "0641-6146"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["DEXAMETHASONE SODIUM PHOSPHATE"], "rxcui": ["309696", "1116927", "1812194"], "spl_id": ["84665497-7e82-4733-bcfd-3177817ac0b3"], "spl_set_id": ["0277cc0a-2fd4-4605-a310-b613be84ee26"], "package_ndc": ["0641-0367-21", "0641-0367-25", "0641-6145-01", "0641-6145-25", "0641-6146-01", "0641-6146-10", "0641-6146-25"], "is_original_packager": [true], "unii": ["AI9376Y64P"]}, "product_type": "Drugs", "event_id": "78415", "recalling_firm": "West-Ward Pharmaceuticals Corp.", "address_1": "401 Industrial Way West", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0093-2018", "product_description": "Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Vials (NDC 0641-6145-01), packaged in 25 x 1 mL Vials per shelf pack (NDC 0641-6145-25), Rx Only, Manufactured by WEST-WARD, Eatontown, NJ 07724 USA.", "product_quantity": "16,157 shelf packs", "reason_for_recall": "Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).", "recall_initiation_date": "20171106", "center_classification_date": "20171122", "termination_date": "20200401", "report_date": "20171129", "code_info": "Lot #: 106390, 106393, 106395, Exp 10/18"}, {"status": "Terminated", "city": "Moon Township", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M022"], "brand_name": ["SENSODYNE"], "generic_name": ["STANNOUS FLUORIDE"], "manufacturer_name": ["Haleon US Holdings LLC"], "product_ndc": ["0135-0547", "0135-0548", "0135-0575"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["STANNOUS FLUORIDE"], "rxcui": ["416784"], "spl_id": ["1309c3eb-8c5c-c532-e063-6394a90a5529"], "spl_set_id": ["34260c69-d829-46c0-b12a-5136ee073ba1"], "package_ndc": ["0135-0548-02", "0135-0548-01", "0135-0547-02", "0135-0575-01"], "is_original_packager": [true], "unii": ["3FTR44B32Q"]}, "product_type": "Drugs", "event_id": "71750", "recalling_firm": "GlaxoSmithkline Consmer Healthcare", "address_1": "1000 GSK Drive", "address_2": "N/A", "postal_code": "15108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico & Taiwan", "recall_number": "D-1323-2015", "product_description": "SENSODYNE EXTRA FRESH REPAIR & PROTECT, 3.4 oz. (96.4 g) tubes, Manufactured by Oratech, South Jordan, UTAH 84095, Distributed by GlaxoSmithKline, Consumer Healthcare, L.P., Moon Township, PA 15108,  NDC 0135-0547-02", "product_quantity": "335,676 tubes", "reason_for_recall": "Presence of Foreign Substance: Fragments of wood found when the product was extruded onto a toothbrush.", "recall_initiation_date": "20150715", "center_classification_date": "20150811", "termination_date": "20170419", "report_date": "20150819", "code_info": "Lot #     Q3H061, Q3H081, Q3H101, Q3H131, Exp 07/15  Q3J101, Q3J121, Q3J261, Q3J291, Exp 08/15  Q3K161, Q3K181, Q3K211, Q3M021, Exp 09/15  Q3M071, QEM251, Exp 10/15  Q3N021, Q3N211, Exp 11/15  Q4A071, Q4A111, Q4A251, Q4B201, Exp 12/15  Q4C151, Q4C191, Exp 12/16  Q4D111, Q4D151, Q4D151R, Exp 03/16  Q4E151, Q4E151R, Q3E152, Exp 04/16  Q4F161, Q4F201, Exp 05/16  Q4G271, Q4G301, Exp 06/16  Q4J051, Exp 08/16"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1043-2023", "product_description": "fentaNYL, 1250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-7", "product_quantity": "5,124 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270664, Exp. 7/18/2023; 17-270886, Exp. 7/20/2023; 17-270976, 17-270989, Exp. 7/23/2023; 17-271335, Exp. 7/27/2023; 17-271572, Exp. 8/1/2023; 17-271747, Exp. 8/3/2023; 17-271808, Exp. 8/6/2023; 17-272023, Exp. 8/9/2023; 17-272203, Exp. 8/13/2023; 17-272718, Exp. 8/21/2023; 17-272797, Exp. 8/22/2023; 17-273157, Exp. 8/29/2023; 17-273507, Exp. 9/4/2023; 17-273766, Exp. 9/7/2023; 17-273862, Exp. 9/10/2023; 17-274052, Exp. 9/12/2023; 17-274208, Exp. 9/14/2023."}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1375-2019", "product_description": "Memantine Hydrochloride Oral Solution, 2 mg/mL, Rx Only, 12 FL. oz.. bottle, NDC: 13668-573-09, Manufactured By Bio-Pharm Inc., Levittown, PA 19057, Manufactured for Torrent Pharma Inc., Basking Ridge, NJ 07920.", "product_quantity": "264 bottles", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #: 18F026, Exp. 06/2020."}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71618", "recalling_firm": "The Apothecary Shoppe LLC", "address_1": "6136 E 51st St", "address_2": "N/A", "postal_code": "74135-7704", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Oklahoma", "recall_number": "D-1312-2015", "product_description": "SO-Acetylcysteine 10% Sterile Ophthalmic Solution, Rx Only, 10 mL bottle, Apothecary Shoppe, Compounding Pharmacy, Tulsa, OK 74135, NDC 13452-2774-94", "product_quantity": "40 mL", "reason_for_recall": "Lack of Assurance of Sterility: Due to lack of documentation of proper environmental monitoring during the time in which the medication was produced.", "recall_initiation_date": "20150626", "center_classification_date": "20150806", "termination_date": "20170217", "report_date": "20150812", "code_info": "Lot #: 05062015@28, BUD 07/05/2015"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0680-2020", "product_description": "BUP 10MG/ FENT 1000MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@29 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-534-2015", "product_description": "Baclofen active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "134535 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Completed", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202332"], "brand_name": ["OXYBUTYNIN"], "generic_name": ["OXYBUTYNIN"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-255", "68382-256", "68382-257"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OXYBUTYNIN CHLORIDE"], "rxcui": ["863619", "863628", "863636"], "spl_id": ["f54e4d4e-91be-4e10-a446-57ed5e1843a1"], "spl_set_id": ["c042bf06-79a3-4dc7-ae05-3ef3cfae9d44"], "package_ndc": ["68382-255-06", "68382-255-14", "68382-255-16", "68382-255-01", "68382-255-05", "68382-255-30", "68382-255-77", "68382-256-14", "68382-256-01", "68382-256-16", "68382-256-05", "68382-256-30", "68382-256-77", "68382-256-06", "68382-257-14", "68382-257-01", "68382-257-16", "68382-257-05", "68382-257-30", "68382-257-77", "68382-257-06"], "is_original_packager": [true], "unii": ["L9F3D9RENQ"]}, "product_type": "Drugs", "event_id": "93260", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0096-2024", "product_description": "Oxybutynin Chloride Extended-Release Tablet USP, 5 mg, 100 count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Baddi, India. Distributed by: Zydus Pharmaceuticals (USA) Inc. NDC # 68382-255-01", "product_quantity": "", "reason_for_recall": "Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.", "recall_initiation_date": "20231019", "center_classification_date": "20231108", "report_date": "20231115", "code_info": "M212749, exp. date  11/2024; M214477, exp. date  11/2024; M214478, exp. date  11/2024; M214479, exp. date  11/2024; M214480, exp. date  11/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202230"], "brand_name": ["LOSARTAN POTASSIUM"], "generic_name": ["LOSARTAN POTASSIUM"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-044", "33342-045", "33342-046"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LOSARTAN POTASSIUM"], "rxcui": ["979480", "979485", "979492"], "spl_id": ["81824d1f-61f4-457c-8723-cd43d5429029"], "spl_set_id": ["85d69d02-c5ef-467e-94aa-903100218795"], "package_ndc": ["33342-044-10", "33342-044-12", "33342-044-07", "33342-044-44", "33342-045-10", "33342-045-12", "33342-045-07", "33342-045-44", "33342-046-10", "33342-046-12", "33342-046-07", "33342-046-44"], "is_original_packager": [true], "unii": ["3ST302B24A"]}, "product_type": "Drugs", "event_id": "90037", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd Bldg 200 Ste 230", "address_2": "N/A", "postal_code": "08536-0009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0833-2022", "product_description": "Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottles (NDC # 33342-045-07), b) 90-count bottles (NDC # 33342-045-10), c) 1000-count bottles (NDC # 33342-045-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536", "product_quantity": "3216/30 count bottles; 47,904/90 count bottles; 4269/1000 count bottles = 8,676,840 tablets", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits", "recall_initiation_date": "20220415", "center_classification_date": "20220503", "termination_date": "20231013", "report_date": "20220511", "code_info": "Lot #  BLI2002A, exp. date 11/2022  BLI2004A, exp. date 11/2022  BLI2104B, exp. date 05/2023"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209433"], "brand_name": ["DEFERASIROX"], "generic_name": ["DEFERASIROX"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-494", "68462-495", "68462-496"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DEFERASIROX"], "rxcui": ["597768", "597770", "597772"], "spl_id": ["e2349a09-1e53-462c-b185-225ca0a400a4"], "spl_set_id": ["59f1d3fb-5bdb-4261-8557-9a4bde8b3c1c"], "package_ndc": ["68462-494-30", "68462-494-90", "68462-495-30", "68462-495-90", "68462-496-30", "68462-496-90"], "is_original_packager": [true], "nui": ["N0000000144", "N0000175522", "N0000185506", "N0000187062", "N0000182138"], "pharm_class_moa": ["Iron Chelating Activity [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]"], "pharm_class_epc": ["Iron Chelator [EPC]"], "unii": ["V8G4MOF2V9"]}, "product_type": "Drugs", "event_id": "93219", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0095-2024", "product_description": "Deferasirox Tablets for Oral Suspension, 500mg, 30-count bottle, Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-496-30", "product_quantity": "5,856 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20231020", "center_classification_date": "20231108", "report_date": "20231115", "code_info": "Lot #: 17220063, Exp 12/2023; 17220396, 17220397, Exp 01/2024; 17220965, Exp 04/2024; 17221187, 17221523, Exp 07/2024; 17221793, 17221794, 17221801, Exp 08/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065129"], "brand_name": ["CEFIXIME"], "generic_name": ["CEFIXIME"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-405", "68180-407", "68180-416", "68180-423"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFIXIME"], "rxcui": ["309058", "409823", "419849"], "spl_id": ["735f86f4-369c-4f5a-adbe-7dacea2e27b4"], "spl_set_id": ["6d68dbd9-7d75-4ff1-91db-79ff8ae879ec"], "package_ndc": ["68180-405-01", "68180-407-03", "68180-407-04", "68180-416-08", "68180-416-11", "68180-423-11", "68180-423-08"], "is_original_packager": [true], "upc": ["0368180423089", "0368180407034", "0368180416081", "0368180416111"], "unii": ["97I1C92E55"]}, "product_type": "Drugs", "event_id": "94723", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0559-2024", "product_description": "Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited, Mandideep, India NDC 68180-407-03", "product_quantity": "3,552 bottles", "reason_for_recall": "Failed Content Uniformity Specifications", "recall_initiation_date": "20240530", "center_classification_date": "20240618", "termination_date": "20250429", "report_date": "20240626", "code_info": "Lot F201519, Expiry: November 2024"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-818-2015", "product_description": "Nitazoxanide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "9550 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1371-2016", "product_description": "0.5 mcg/mL Sufentanil Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Yellow Smiths Medical Cassette,  Service Code 2T8317, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-317-52", "product_quantity": "325 Medical Cassettes", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Lot Number 160960175M; Exp. Date 5/6/2016   Lot Number 160970036M; Exp. Date 5/7/2016   Lot Number 161080071M; Exp. Date 5/18/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87547", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to MD, CO & TX only", "recall_number": "D-0322-2021", "product_description": "Sp-4, 100 mL solution bottles, Rx only, Washington Homeopathic Products, Inc.260 J R Hawvermale Way  Berkeley Springs West Virginia 25411", "product_quantity": "114 bottles", "reason_for_recall": "An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.", "recall_initiation_date": "20210318", "center_classification_date": "20210405", "termination_date": "20210513", "report_date": "20210414", "code_info": "Lot # 24844, 25500, 26310"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "500 mL in Vials", "code_info": "Lot #: 160203-41, BUD: 08/01/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "L-CARNITINE 500MG/ML (PF), 10ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1197-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73044", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0587-2016", "product_description": "Guaifenesin DM Cherry liquid (guaifenesin 100 mg/5 mL and Dextromethorphan HBr 5 mg/5 mL), packaged in 4oz. bottles, co-packaged with a dosing cup in a carton and sold under the following: a) Sunmark, Children's Mucus Relief Cough, Guaifenesin 100 mg/Expectorant, Dextromethorphan HBr 5 mg/Cough Suppressant, Cherry Flavor, 4 FL OZ (118 mL) Bottle, Alcohol Free, Gluten Free, Distributed by: McKesson, San Francisco, CA 94104, NDC 49348-828-34; b) Rite-Aid, Children's Mucus Relief Cough, Guaifenesin 100 mg/Expectorant, Dextromethorphan HBr 5 mg/Cough Suppressant, Cherry Flavor, 4 FL OZ (118 mL) Bottle, Alcohol Free, Distributed by: Rite-Aid, Camp Hill, PA 17011, NDC 11822-0419-1; c) Topcare, Children's Mucus Relief Cough, Guaifenesin 100 mg/Expectorant, Dextromethorphan HBr 5 mg/Cough Suppressant, Cherry Flavor, 4 FL OZ (118 mL) Bottle, Alcohol Free, Distributed by: Topco Associates LLC, Elk Grove Village, IL 60007, NDC 36800-419-26; d) Kroger, Children's Mucus Relief Cough, Guaifenesin 100 mg/Expectorant, Dextromethorphan HBr 5 mg/Cough Suppressant, Cherry Flavor, 4 FL OZ (118 mL) Bottle, Distributed by: The Kroger Co., Cincinnati, OH 46202, NDC 30142-419-26; e) GoodSense, Children's Mucus Relief Cough, Guaifenesin 100 mg/Expectorant, Dextromethorphan HBr 5 mg/Cough Suppressant, Cherry Flavor, 4 FL OZ (118 mL) Bottle, Alcohol Free, Gluten Free, Distributed by: Perrigo, Allegan, MI 49010, NDC 0113-0419-26; f) Dollar General, Children's Mucus Relief Cough, Guaifenesin 100 mg/Expectorant, Dextromethorphan HBr 5 mg/Cough Suppressant, Cherry Flavor, 4 FL OZ (118 mL) Bottle, Alcohol Free, Distributed by: DolgenCorp, LLC, Goodlettsville, TN 37072, NDC 55910-419-26; g) Care One, Children's Mucus Relief Cough, Guaifenesin 100 mg/Expectorant, Dextromethorphan HBr 5 mg/Cough Suppressant, Cherry Flavor, 4 FL OZ (118 mL) Bottle, Gluten Free, Distributed by: American Sales Company, Lancaster, NY 14086, NDC 41520-419-26; h) CVS, Children's Mucus Relief Cough, Guaifenesin 100 mg/Expectorant, Dextromethorphan HBr 5 mg/Cough Suppressant, Cherry Flavor, 4 FL OZ (118 mL) Bottle, Distributed by: CVS Pharmacy Inc, Woonsocket, RI 02895.", "product_quantity": "N/A", "reason_for_recall": "Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups.", "recall_initiation_date": "20160108", "center_classification_date": "20160122", "termination_date": "20160518", "report_date": "20160203", "code_info": "Lot #s: 5LK0528, 5LK0630, 5LK0779, Exp 03/17"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0734-2018", "product_description": "Humira Pen Sub-q Kit a.) 40 mg/0.8 mL (NDC 00074-4339-02); Humira Pen Psor Kit b.) 40 mg/0.8 mL (NDC 00074-4339-07) 28 day supply, Rx Only,", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1056-2022", "product_description": "Metronidazole tablets, USP 250 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-1453-61", "product_quantity": "3 boxes/100 blisters per box", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s:   0374732    0374732", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "STRONTIUM 1 MG/ML INJECTABLE\t30 ML  \t60 ML  (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1619-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0387-2020", "product_description": "CVS Health Fast Acting Lubricant Eye Drops (Polyethylene Glycol 400, 0.4% Propylene Glycol 0.3%) Dry Eye Therapy, Sterile, 0.5 fl. oz. (15 mL), Item #895160, Distributed by: CVS Pharmacy Inc., One CVS Drive, Woonsocket, RI 02895", "product_quantity": "238,968 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: 17223 07/19  17297 10/19  18017 01/20  18018 01/20  18065 03/21  18213 08/20  18247 10/21"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64405", "recalling_firm": "Dr Reddys Laboratories Tennessee LLC", "address_1": "201 Industrial Dr", "address_2": "N/A", "postal_code": "37620-5413", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-239-2013", "product_description": "Amoxicillin for Oral Suspension, 125mg/5mL,  a) 80 mL (NDC 43598-222-80); b) 100mL, (NDC 43598-222-52); c)150 mL (NDC 43598-222-53) bottles, Rx only, Dist. By:  Dr. REDDY'S Laboratories, Inc., Bridgewater, NJ  08807", "product_quantity": "4236 Bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Suspensions made from these lots of Amoxicillin 125 mg/5 mL showed yeast and mold growth at the 14 day time point.", "recall_initiation_date": "20130215", "center_classification_date": "20130402", "termination_date": "20131001", "report_date": "20130410", "code_info": "Lot #s: a) T200112; b) T200103, T200113; c) T200104, T200114"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0437-2018", "product_description": "Morphine Sulfate in 5% Dextrose in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: TACROLIMUS, Capsule, 1 mg may have potentially been mislabeled as one of the following drugs:  BISOPROLOL FUMARATE, Tablet, 5 mg, NDC 29300012601, Pedigree: AD34934_7, EXP: 5/10/2014;  SEVELAMER CARBONATE, Tablet, 800 mg, NDC 58468013001, Pedigree: AD56917_4, EXP: 5/21/2014;  SEVELAMER CARBONATE, Tablet, 800 mg, NDC 58468013001, Pedigree: AD73627_11, EXP: 5/30/2014;  ATOMOXE", "address_2": "", "product_quantity": "700 Capsules", "code_info": "TACROLIMUS, Capsule, 1 mg has the following codes:   Pedigree: AD37056_1, EXP: 5/10/2014;  Pedigree: AD56917_7, EXP: 5/21/2014;  Pedigree: AD73627_14, EXP: 5/30/2014;  Pedigree: W003704, EXP: 6/26/2014;  Pedigree: W002508, EXP: 6/3/2014;  Pedigree: W003049, EXP: 6/12/2014;  Pedigree: W003352, EXP: 3/31/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "TACROLIMUS, Capsule, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781210301.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1007-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lewis Center", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "64611", "recalling_firm": "Shamrock Medical Solutions Group LLC", "address_1": "741 Radio Dr", "address_2": "", "postal_code": "43035-7134", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Product was shipped to the following states: CO, MA, OH, TX & WY.", "recall_number": "D-1448-2014", "product_description": "metFORMIN ER Tablets, 500 mg, Rx, Packaged and labeled as metFORMIN Immediate Release (IR), Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfr: Amneal/Interpharm, Hauppauge, NY  NDC 53746-178-01", "product_quantity": "88/5 mg tablets", "reason_for_recall": "Labeling: Label Mix up; product labeled did not indicated Extended Release", "recall_initiation_date": "20110927", "center_classification_date": "20140723", "termination_date": "20140731", "report_date": "20140730", "code_info": "Lot #: 00267J Use By: 7/28/2012 NDC: 53746-178-01", "more_code_info": ""}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "B0112 exp 08/31/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Acepromazine 25 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-693-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Gummidipoondi", "state": "N/A", "country": "India", "classification": "Class III", "openfda": {"application_number": ["ANDA214380"], "brand_name": ["MILRINONE LACTATE"], "generic_name": ["MILRINONE LACTATE"], "manufacturer_name": ["Armas Pharmaceuticals Inc."], "product_ndc": ["72485-501", "72485-502", "72485-503"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["MILRINONE LACTATE"], "rxcui": ["1791854", "1791859", "1791861"], "spl_id": ["fde1e354-4f15-4ade-9ae3-db2ba67e0431"], "spl_set_id": ["fde1e354-4f15-4ade-9ae3-db2ba67e0431"], "package_ndc": ["72485-501-01", "72485-501-10", "72485-502-01", "72485-502-10", "72485-503-01"], "is_original_packager": [true], "upc": ["0372485503018", "0372485501014", "0372485502011", "0372485502103"], "unii": ["9K8XR81MO8"]}, "product_type": "Drugs", "event_id": "92900", "recalling_firm": "Caplin Steriles Limited", "address_1": "895 & 897 Survey No", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in Tennessee", "recall_number": "D-1144-2023", "product_description": "Milrinone Lactate Injection, USP 20mg/20 mL (1mg/mL), packaged in 10 x 20 mL vials per carton, NDC 72485-502-01 (single vial), Rx only, Distributed by: Armas Pharmaceuticals, Inc. Freehold, NJ 07728(USA) Manufactured by: Caplin Steriles Limited, India, NDC 72485-502-10", "product_quantity": "19, 820 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230814", "center_classification_date": "20230906", "termination_date": "20250909", "report_date": "20230913", "code_info": "Lot #: 90000228"}, {"status": "Terminated", "city": "Hayward", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "73551", "recalling_firm": "Impax Laboratories, Inc.", "address_1": "31153 San Antonio Street", "address_2": "N/A", "postal_code": "94544", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0820-2016", "product_description": "Fenofibrate Capsules (Micronized) 134 mg, 500-count bottle, Rx Only, Distributed by Impax Generics, Hayward, CA 94544, NDC 0115-0522-02", "product_quantity": "28,001 HDPE bottles (14,000,500 capsules)", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp. Date", "recall_initiation_date": "20160317", "center_classification_date": "20160414", "termination_date": "20161027", "report_date": "20160420", "code_info": "Lot # 10008624, 10008831; Exp. 10/16  Lot # 10009339; Exp. 02/17  Lot # 10009566,10009627; Exp. 04/17  Lot # 10010200, 20001419A, 20001426A; Exp. 10/17  Lot # 20001732A; Exp. 04/18  Lot # 20001790A, 20001791A, 20001792A; Exp. 05/18", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: sitaGLIPtin PHOSPHATE, Tablet, 50 mg may be potentially mis-labeled as one of the following drugs:  LACTOBACILLUS, Tablet, 0 mg, NDC 64980012950, Pedigree: AD62992_1, EXP: 5/23/2014;  CYANOCOBALAMIN, Tablet, 500 mcg, NDC 00536355101, Pedigree: W002860, EXP: 6/7/2014.", "address_2": "", "product_quantity": "60 Tablets", "code_info": "sitaGLIPtin PHOSPHATE, Tablet, 50 mg has the following codes:   Pedigree: AD62829_11, EXP: 5/23/2014;  Pedigree: W002824, EXP: 6/7/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "sitaGLIPtin PHOSPHATE, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00006011231.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-774-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Charles City", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76166", "recalling_firm": "Cambrex Charles City Inc", "address_1": "1205 11th St", "address_2": "N/A", "postal_code": "50616-3466", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Product distributed solely to the state of Minnesota.", "recall_number": "D-0447-2017", "product_description": "Mesalamine, U.S.P. [CAS 89-57-6] Cambrex Charles City, Inc. Charles City, IA packaged in double lined PE liners inside Poly-lined cardboard drums. Net weight 40 kg", "product_quantity": "2351.12 pound container", "reason_for_recall": "Presence of Particulate Matter: Stainless steel in a chemical reactor dissolved into the API solution and was detected in the finished product.", "recall_initiation_date": "20140520", "center_classification_date": "20170126", "termination_date": "20170309", "report_date": "20170201", "code_info": "Code 1661911; Batch 1340;  Exp. 03/17"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; METHYLERGONOVINE MALEATE Tablet, 0.2 mg may be potentially mislabeled as     ISOSORBIDE MONONITRATE, Tablet, 20 mg, NDC 62175010701, Pedigree: AD52778_31, EXP: 5/20/2014;  LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00378180701, Pedigree: W003476, EXP: 6/20/2014.", "address_2": "", "product_quantity": "112 Tablets", "code_info": "METHYLERGONOVINE MALEATE, Tablet, 0.2 mg has the following codes    Pedigree: AD52778_40, EXP: 5/20/2014;  Pedigree: W003477, EXP: 6/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "METHYLERGONOVINE MALEATE Tablet, 0.2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 43386014028", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-563-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: C247 BUD: 11/30/2018; C249 BUD: 12/5/2018; C266 BUD: 12/29/2018; D012 BUD: 1/12/2019; D029 BUD: 2/2/2019", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Testosterone 50mg pellet, 1 count (NDC 69761-150-01), 6 count (NDC 69761-150-06), 12 count (NDC 69761-150-12), and 30 count (NDC 69761-150-30) vials, Rx Only Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0236-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA062341"], "brand_name": ["NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE"], "generic_name": ["NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE"], "manufacturer_name": ["Sandoz Inc."], "product_ndc": ["61314-630"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["DEXAMETHASONE", "NEOMYCIN SULFATE", "POLYMYXIN B SULFATE"], "rxcui": ["309680"], "spl_id": ["c28e6969-112d-49ae-b037-f09954e99f3e"], "spl_set_id": ["cf1a6da8-ba79-4bff-a13b-6effb67f6c1c"], "package_ndc": ["61314-630-06"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["7S5I7G3JQL", "057Y626693", "19371312D4"]}, "product_type": "Drugs", "event_id": "84082", "recalling_firm": "Sandoz Inc", "address_1": "100 College Rd W", "address_2": "", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0162-2020", "product_description": "Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension, Rx Only, Sterile, 5 mL bottle, Manufactured by Alcon Laboratories, Inc. Fort Worth, Texas 76134 for Sandoz Inc. Princeton, NJ 08540, NDC 61314-630-06", "product_quantity": "346,929 bottles", "reason_for_recall": "Labeling: Incorrect or missing package insert.", "recall_initiation_date": "20191017", "center_classification_date": "20191028", "termination_date": "20220119", "report_date": "20191106", "code_info": "Lot #s: 287880F, 287881F, Exp. 10/31/2019; 290555F, Exp. 11/30/2019; 293389F, Exp. 2/29/2020; 290556F, 290557F, 293386F, 293387F, Exp. 3/31/2020; 293388F, 293390F, Exp. 5/31/2020; 293391F, Exp. 6/30/2020; 293392F, Exp. 7/31/2020; 295342F, 298823F, Exp. 8/31/2020; 295344F, 295345F, 295346F, Exp. 10/31/2020; 295347F, 304496F, Exp. 11/30/2020; 298825F, Exp. 12/31/2020; 304495F, 304497F, Exp. 01/31/2021; 304963F, Exp. 3/31/2021; 304966F, Exp. 4/30/2021; 304964F, Exp. 5/31/2021.", "more_code_info": ""}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1 container", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Tri-Mix LOW ED Injection, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0482-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73491", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0875-2016", "product_description": "Chlorhexidine gluconate, oral rinse, 0.12% packaged in 16 fl. oz. (473 mL) PET bottle, Rx only, Manufactured by HI-TECH PHARMACAL CO., INC., Amityville, NY 11701, NDC 5083-0720-16", "product_quantity": "3,112,657 mL", "reason_for_recall": "Failed impurities/degradation specifications: Out-of-specification result (for multiple batches) for an unknown impurity of Chlorhexidine gluconate.", "recall_initiation_date": "20160323", "center_classification_date": "20160525", "termination_date": "20171130", "report_date": "20160601", "code_info": "Lot # 627528, 627763, 627766, 627921, 627924, 627927, 627930, 627933, 627953, 627956, 627959, 628040, Exp 5/16; 628148, 628151, 628230, 628232, 628365, Exp 6/16; 628589 , 628592, 628598, 628802, 628805, 628808, 628811, 628814, Exp 7/16 ; 629059, 629204, 629207, 629232, 629235, 629307, 629310, 629313, 629316, Exp 8/16; 629687, 629693, 629696, 629882, 629888, 630058, Exp 9/16; 630061, 630064, 630221, 630224, 630362, 630365, 630613, Exp 10/16; 630615, 630732, 630735, 630853, 630856, 630859, 631008, Exp 11/16; 631026, 631027, 631169, 631172, 631175, 631655, 631658, Exp 12/16; 631704, 631707, 631861, 631864, 631867, 632059, 632062, 632065, 632068, 632071, 632074, 632211, 632214 Exp 1/17; 632328, 632331, 632334, 632337, 632472, 632475, 632504, 632507, 632697, Exp 2/17; 633090, 633093, 632776, 632781, 632784, 632790, 632793, 632796, 632805, 632808, 632811, 632814, 633072, 633078, 633081, 633084, 633087, Exp 3/17; 633681, 633682, 633099, 633684, 633111, Exp 4/17; 345607, 345618, 345620, Exp 5/17; 346575, 346863, 346571, 346720,3 46573, Exp 7/17"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA086195"], "brand_name": ["PROCTOFOAM"], "generic_name": ["PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["0037-6822"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["HYDROCORTISONE ACETATE", "PRAMOXINE HYDROCHLORIDE"], "rxcui": ["828362", "828364"], "spl_id": ["d63033a1-dca0-44f9-a6f3-210e38c2691e"], "spl_set_id": ["3831e931-ec0a-11e3-ac10-0800200c9a66"], "package_ndc": ["0037-6822-10"], "is_original_packager": [true], "unii": ["3X7931PO74", "88AYB867L5"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0529-2021", "product_description": "Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol 10 g net wt Rx Only NDC 0037-6822-10 Distributed by: Meda Pharmaceutical Inc. Somerset, New Jersey", "product_quantity": "834 aerosol containers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "33119"}, {"status": "Terminated", "city": "Bellflower", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72361", "recalling_firm": "Pacific Healthcare, Inc dba B&B Pharmacy", "address_1": "10244 Rosecrans Ave", "address_2": "N/A", "postal_code": "90706-2602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA and NJ", "recall_number": "D-0177-2016", "product_description": "PGE 30mcg/ml Injection, 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA", "product_quantity": "4 vials", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "recall_initiation_date": "20151007", "center_classification_date": "20151110", "termination_date": "20160407", "report_date": "20151118", "code_info": "07062015@8, exp 1/2/2016; 07162015@7, exp 1/12/2016; 07272015@5, exp 1/23/2016; 08142015@9, exp 2/10/2016"}, {"status": "Ongoing", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M007"], "brand_name": ["MAGNESIUM CITRATE"], "generic_name": ["MAGNESIUM CITRATE"], "manufacturer_name": ["AMERISOURCE BERGEN"], "product_ndc": ["46122-741"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "rxcui": ["1052760"], "spl_id": ["29f9080b-baf4-6e18-e063-6294a90a46a2"], "spl_set_id": ["f3847b0f-802d-73d7-e053-2a95a90a5bbe"], "package_ndc": ["46122-741-38"], "is_original_packager": [true], "unii": ["RHO26O1T9V"]}, "product_type": "Drugs", "event_id": "93682", "recalling_firm": "Pharma Nobis LLC", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide.", "recall_number": "D-0227-2024", "product_description": "Good Neighbor Pharmacy, DYE FREE, SUGAR FREE Magnesium Citrate Saline Laxative, Oral Solution, Cherry Flavor 10 fl. oz, Distributed by AmerisourceBergen, 1 West First Ave, Conshochoken, PA 19428, NDC 46122-741-38", "product_quantity": "24,684 Bottles", "reason_for_recall": "MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.", "recall_initiation_date": "20231221", "center_classification_date": "20240112", "report_date": "20240124", "code_info": "Lots A80673, A80742; Exp 10/31/2025"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1201-2020", "product_description": "Bi-Est 1:1/Progest/DHEA 0.5 mg/180 mg/25 mg/mL Cream 30 mL jar, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 tube", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 44850 Discard by: 6/4/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0248-2024", "product_description": "Secret OUTLAST Dry Spray, (Aluminum chlorohydrate 23.5%), Antiperspirant, Protecting Powder, Topical spray can 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-478-10, UPC 0 37000 74772 7", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September, 2023"}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89656", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0642-2022", "product_description": "Alprazolam Tablets, USP 1mg, Generic for Xanax, Pkg Size: a) 30 tablets per bottle, NDC: 68788-6381-03, b) 60 tablets per bottle, NDC: 68788-6381-06, c) 90 tablets per bottle, NDC: 68788-6381-09, Mfg: Par Pharmaceutical.", "product_quantity": "276 bottles", "reason_for_recall": "CGMP deviations", "recall_initiation_date": "20220222", "center_classification_date": "20220301", "termination_date": "20230505", "report_date": "20220309", "code_info": "Lot #s: a) G2919M, I0619O, F1419J; b) H3019Q; c) F1219N, F1919D, H0219D, I0519R, J0319G, Exp. 03/31/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA202236"], "brand_name": ["DYMISTA"], "generic_name": ["AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["0037-0245"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["NASAL"], "substance_name": ["AZELASTINE HYDROCHLORIDE", "FLUTICASONE PROPIONATE"], "rxcui": ["1797847", "1797849"], "spl_id": ["ed1f7ce9-ccfa-4e73-940f-14ea8166d524"], "spl_set_id": ["4c557ec4-c4cf-11df-851a-0800200c9a66"], "package_ndc": ["0037-0245-23"], "is_original_packager": [true], "unii": ["0L591QR10I", "O2GMZ0LF5W"]}, "product_type": "Drugs", "event_id": "81980", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0424-2019", "product_description": "Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg/50 mcg per spray, 120 Metered Sprays, 23 g net fill weight bottle, Rx Only, Manufactured by: Cipla Ltd., Goa, India, M.L. No. 546; For: Meda Pharmaceuticals Inc., Somerset, New Jersey 08873-4120, NDC 0037-0245-23.", "product_quantity": "10,390 bottles", "reason_for_recall": "Defective Container: Potential for broken glass in the neck area of the glass bottles.", "recall_initiation_date": "20190201", "center_classification_date": "20190204", "termination_date": "20190909", "report_date": "20190213", "code_info": "Lot: GA70535, Exp. April 2019", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "87 units", "code_info": "Rx #'s:   0387290    0387290    0400922    0405419    0362272        0362272      0392196    0392211    0389062    0402046    0366190        0376388    0377225    0363673    0355420    0394877    0359658    0361833    0376569    0390305    0394394    0394710    0397895    0399493    0402872    0403787    0394877    0365100    0390365    0391344    0391346    0391866    0405531    0355420      0399719      0365828        0394562    0380506    0406925    0398935    0387737    0387737    0401220    0404375    0387737    0395444    0398847    0360739    0365769        0365769    0404497    0407975    0408999    0351511    0398847    0361324    0403770    0410188    0405655    0365764    0403770    0406991    0365769    0403770    0407885    0403574    0403577    0404165    0403579    0392063    0400699    0397870    0397870    0402420    0402420    0406941", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TRIAMCINOLONE ACETONIDE  4MG/ML (0.4MG/0.1ML) INJECTABLE\t10 ML  \t5 ML  TRIAMCINOLONE ACETONIDE (T), STSL (0.025ML SYRINGE, 30G, 1/2\") 40MG/ML (4MG/0.1M\t0.075 SYR  \t0.1 SYR  TRIAMCINOLONE ACETONIDE 0.25ML SYRINGE (T) 40MG/ML (4MG/0.1ML) OPHTHALMIC\t0.25 ML  \t  \t  \t0.5 ML  \t  TRIAMCINOLONE ACETONIDE 20MG/ML INJECTABLE\t1 ML  TRIAMCINOLONE ACETONIDE 80MG/ML INJECTABLE\t100 ML  TRIAMCINOLONE ACETONIDE IN VITREOUS VEHICLE, P.F. 10MG/ML (1MG/0.1ML) OPHTHALMIC\t0.1 ML  \t  \t50 ML  \t  \t  TRIAMCINOLONE ACETONIDE IN VITREOUS VEHICLE, P.F. 20MG/ML (2MG/0.1ML) OPHTHALMIC\t0.1 ML  \t  \t0.2 ML  TRIAMCINOLONE ACETONIDE IN VITREOUS VEHICLE, P.F. 40MG/ML (4MG/0.1ML) OPHTHALMIC\t0.05 ML  \t  \t0.1 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t0.15 ML  \t0.2 ML  \t  \t  \t  \t  \t  \t0.25 ML  \t  \t  \t  \t0.5 ML  \t  \t  \t  \t0.6 ML  \t0.75 ML  \t0.8 ML  \t0.9 ML  \t1 ML  \t  \t  \t1.2 ML  \t  \t1.25 ML  \t10 ML  \t  \t  \t  \t14 ML  \t2 ML  \t  \t  \t2.5 ML  \t  \t3 ML  \t  \t30 ML  \t360 ML  \t4 ML  \t  \t5 ML  \t6 ML  \t8 ML  TRIAMCINOLONE ACETONIDE IN VITREOUS VEHICLE, P.F. 80MG/ML (8MG/0.1ML) OPHTHALMIC\t0.25 ML  \t0.3 ML  \t0.5 ML  \t0.75 ML  \t2 ML  TRIAMCINOLONE ACETONIDE P.F. (OPHTHALMIC) 40MG/ML (4MG/0.1ML) OPHTHALMIC\t1 ML  \t10 ML  TRIAMCINOLONE ACETONIDE, P.F. 80MG/ML INJECTABLE\t150 ML  \t75 ML  TRIAMCINOLONE DIACETATE 40MG/ML INJECTABLE\t3 ML  \t4 ML  TRIAMCINOLONE DIACETATE, PRESERVATIVE FREE 40MG/ML INJECTABLE\t360 ML  (48 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1628-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89172", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide", "recall_number": "D-0412-2022", "product_description": "MVASI, (bevacizumab-awwb), Sterile Ophthalmic Solution for Injection, 3.25mg/0.13mL (25 mg/mL) 0.13 mL per syringe, Dose: 1.25mg/0.05mL, Single Use Syringe For Intraocular Injection, Edge Pharma, LLC, 856 Hercules Dr. Colchester, VT 05446,  NDC 05446-1661-13", "product_quantity": "199 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211206", "center_classification_date": "20220124", "termination_date": "20230607", "report_date": "20220202", "code_info": "11-2021-01@2 12/15/2021", "more_code_info": ""}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "40", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Bupivacaine HCI 0.125% 50 mL fill in a 60 mL syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0608-75", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1288-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pine Brook", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA202097"], "brand_name": ["FENTANYL SYSTEM"], "generic_name": ["FENTANYL"], "manufacturer_name": ["ALVOGEN"], "product_ndc": ["47781-423", "47781-424", "47781-426", "47781-427", "47781-428"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["FENTANYL"], "rxcui": ["197696", "245134", "245135", "245136", "577057"], "spl_id": ["25508d17-4c96-00d3-e063-6294a90a3222"], "spl_set_id": ["242759ef-cb6d-4e3e-9f8d-5e31efa1f289"], "package_ndc": ["47781-423-11", "47781-423-47", "47781-424-11", "47781-424-47", "47781-426-11", "47781-426-47", "47781-427-11", "47781-427-47", "47781-428-11", "47781-428-47"], "is_original_packager": [true], "nui": ["N0000175684", "N0000175690"], "pharm_class_moa": ["Full Opioid Agonists [MoA]"], "pharm_class_epc": ["Opioid Agonist [EPC]"], "unii": ["UF599785JZ"]}, "product_type": "Drugs", "event_id": "82669", "recalling_firm": "Alvogen, Inc", "address_1": "10 Bloomfield Ave Bldg B Ste 2", "address_2": "N/A", "postal_code": "07058-9743", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1277-2019", "product_description": "FENTANYL Transdermal System, 12 mcg/h, five (12 mcg/h) systems per carton, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ  07058; Manufactured by: 3M Drug Delivery Systems, St. Paul, MN  55107, NDC 47781-423-47.", "product_quantity": "119,608 cartons", "reason_for_recall": "Product Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contained five patches labeled and containing 50 mcg/h.", "recall_initiation_date": "20190419", "center_classification_date": "20190513", "termination_date": "20190814", "report_date": "20190515", "code_info": "Lot#: 180060, Exp 05/2020; 180073, Exp 06/2020."}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0240-2020", "product_description": "S-METHYLCOBALAMIN 1,000MCG/ML MDV INJ; a) 10ml, b) 30 ml glass vial, Rx Only, Red mountain Compounding RX", "product_quantity": "60x 10 and 30 ML glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #: a) S05162019DH@10, EXP 08/16/2019,S05242019DT@07, EXP 8/24/19,  S07182019DT@14 EXP 10/18/19,   b) S05162019DH@18, Exp 8/16/19;S07102019DT@04, EXP 10/10/19,S07262019DH@10 EXP 10/26/19, S07292019DH@10 EXP 10/29/19"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-511-2015", "product_description": "Amikacin Sulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "7500 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DUTASTERIDE, Capsule, 0.5 mg may have potentially been mislabeled as one of the following drugs:  DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375701, Pedigree: AD65457_19, EXP: 5/24/2014;  DOCUSATE SODIUM, Capsule, 250 mg, NDC 00904789159, Pedigree: AD56924_1, EXP: 5/21/2014;  PYRIDOXINE HCL, Tablet, 50 mg, NDC 00904052060, Pedigree: W003257, EXP: 6/17/2014.", "address_2": "", "product_quantity": "270 Capsules", "code_info": "DUTASTERIDE, Capsule, 0.5 mg has the following codes:   Pedigree: AD65475_1, EXP: 5/28/2014;  Pedigree: AD54519_1, EXP: 5/21/2014;  Pedigree: W003247, EXP: 6/17/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DUTASTERIDE, Capsule, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00173071204.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-872-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Eatontown", "address_1": "465 Industrial Way W", "reason_for_recall": "Subpotent Drug", "address_2": "", "product_quantity": "1,185 Bottles", "code_info": "Lot #: 69001A", "center_classification_date": "20130212", "distribution_pattern": "OH", "state": "NJ", "product_description": "Glycopyrrolate Tablets, USP, 1 mg, Rx Only, 100 tablets per bottle, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ, 07724, NDC 0143-1250-01.", "report_date": "20130220", "classification": "Class III", "openfda": {}, "recalling_firm": "West-ward Pharmaceutical Corp.", "recall_number": "D-164-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64108", "termination_date": "20140516", "more_code_info": "", "recall_initiation_date": "20130107", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Gurabo", "address_1": "Carr # 933 Km 0.1", "reason_for_recall": "Microbial Contamination of Non-Sterile Products:  Consumer complaint confirmed microbial contamination in sales sample.", "address_2": "Mamey Ward", "product_quantity": "13500 bottles", "code_info": "Lot 13JG2616 Exp. 07/16", "center_classification_date": "20141003", "distribution_pattern": "Nationwide", "state": "PR", "product_description": "Xarelto (rivaroxaban) Tablets 15 mg per tablet, 5 count bottle, Rx Only, Manufactured by: JOLLC, Gurabo, PR 00778 NDC 50458-578-99", "report_date": "20141015", "classification": "Class II", "openfda": {}, "recalling_firm": "Janssen Ortho L.L.C.", "recall_number": "D-0006-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "69302", "termination_date": "20161011", "more_code_info": "", "recall_initiation_date": "20140917", "postal_code": "00778", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Malvern", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA077171"], "brand_name": ["CLONAZEPAM"], "generic_name": ["CLONAZEPAM"], "manufacturer_name": ["Par Health USA, LLC"], "product_ndc": ["49884-306", "49884-307", "49884-308", "49884-309", "49884-310"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLONAZEPAM"], "rxcui": ["349194", "349195", "349196", "349197", "349198"], "spl_id": ["8b72ac75-deb8-4acf-b411-9dd5d13dd51c"], "spl_set_id": ["1aef0069-80ea-483d-ac70-c8d485462c5b"], "package_ndc": ["49884-306-02", "49884-307-02", "49884-308-02", "49884-309-02", "49884-310-02", "49884-306-52"], "is_original_packager": [true], "upc": ["0349884308025"], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["5PE9FDE8GB"]}, "product_type": "Drugs", "event_id": "95778", "recalling_firm": "Endo USA, Inc.", "address_1": "1400 Atwater Dr", "address_2": "", "postal_code": "19355-8701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0179-2025", "product_description": "Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-306-02 (carton), NDC #: 49884-306-52 (blisters).", "product_quantity": "8,029 cartons", "reason_for_recall": "Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.", "recall_initiation_date": "20241118", "center_classification_date": "20250103", "report_date": "20250115", "code_info": "Lot #: 550174101, Exp. 01/31/2027.", "more_code_info": ""}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1 container", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Calcium Chloride Dihydrate Injection, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0421-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "7 Bags", "code_info": "Compounded on 05/28/15, Discard After: 06/11/15", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "Vancomycin, VANCOMYCIN 750mg / NS 100mL AccuFlo, Qty: 7 100 mL Bags, Rx Only.  Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1188-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88550", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0297-2022", "product_description": "Betamethasone Dipropionate Lotion USP, 0.05% (Augmented), 30 mL bottle, (29 g), Rx Only,  Teligent Pharma Inc., Buena, NJ, 08310, NDC 52565-023-29", "product_quantity": "3,792 bottles", "reason_for_recall": "Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API) particle test, which was determined through routine stability testing", "recall_initiation_date": "20210823", "center_classification_date": "20211228", "termination_date": "20240816", "report_date": "20220105", "code_info": "Lot # 16569, Exp 9/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Guadalupe", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86271", "recalling_firm": "GRUPO YACANA MEXICO SAS DE CV", "address_1": "Avenida Alfonso Reyes 714", "address_2": "Fracc. Contry La Silla, Guadalupe", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "TX", "recall_number": "D-1590-2020", "product_description": "Yacana Alcohol Antiseptic 70% Topical Solution 8.5 oz (250 mL), OTC, Manufactured by: Grupo Yacana Mexico SAS de CV Ave. Alfonso reyes 714 Col. Contry La Silla, Monterrey, Nuevo Leon, Mexico Tel. +52 812473-8453,  NDC # 76592-002-04, UPC 6 03765 37699 3", "product_quantity": "55,560 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20200818", "center_classification_date": "20200922", "termination_date": "20230517", "report_date": "20200930", "code_info": "All lots"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0194-2023", "product_description": "Atropine sulfate 0.05%, 1ML dropper, and Atropine sulfate 0.01%, 1 ML dropper, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221025@32 t20221025@33", "more_code_info": ""}, {"status": "Terminated", "city": "Wilton", "state": "CT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88770", "recalling_firm": "Beiersdorf Inc", "address_1": "45 Danbury Rd", "address_2": "N/A", "postal_code": "06897-4405", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0013-2022", "product_description": "Coppertone SPORT MINERAL 50 Sunscreen Spray (To Deliver) Zinc Oxide 24.08%, NET WT 5 OZ (142 g) can, Beiersdorf Inc., Wilton, CT 06897  UPC 0 72140 02870 1", "product_quantity": "142,236 cans", "reason_for_recall": "Chemical contamination; presence of benzene", "recall_initiation_date": "20210930", "center_classification_date": "20211015", "termination_date": "20230413", "report_date": "20211027", "code_info": "Lot# TN008KU, exp. date 03/31/2023 TN008KV, exp. date 03/31/2023"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203874"], "brand_name": ["AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM"], "generic_name": ["AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM"], "manufacturer_name": ["Dr. Reddy's Laboratories Inc"], "product_ndc": ["43598-313", "43598-323", "43598-320", "43598-317", "43598-322", "43598-319", "43598-316", "43598-314", "43598-321", "43598-318", "43598-315"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["404011", "404013", "597967", "597971", "597974", "597977", "597980", "597984", "597987", "597990", "597993"], "spl_id": ["54058ac6-94e2-d2d3-5c46-886b3478fc76"], "spl_set_id": ["abee4a34-89cc-d886-192c-32582ab8f024"], "package_ndc": ["43598-323-30", "43598-323-60", "43598-323-90", "43598-323-05", "43598-320-30", "43598-320-60", "43598-320-90", "43598-320-05", "43598-317-30", "43598-317-60", "43598-317-90", "43598-317-05", "43598-322-30", "43598-322-60", "43598-322-90", "43598-322-05", "43598-319-30", "43598-319-60", "43598-319-90", "43598-319-05", "43598-316-30", "43598-316-60", "43598-316-90", "43598-316-05", "43598-314-30", "43598-314-60", "43598-314-90", "43598-314-05", "43598-321-30", "43598-321-60", "43598-321-90", "43598-321-05", "43598-318-30", "43598-318-60", "43598-318-90", "43598-318-05", "43598-315-30", "43598-315-60", "43598-315-90", "43598-315-05", "43598-313-30", "43598-313-60", "43598-313-90", "43598-313-05"], "is_original_packager": [true], "upc": ["0343598323305", "0343598315300", "0343598320304", "0343598317304", "0343598313306", "0343598322308", "0343598319308", "0343598316307", "0343598314303"], "unii": ["864V2Q084H", "48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "71375", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1143-2015", "product_description": "Amlodipine besylate and Atorvastatin calcium tablets, 5mg/10mg, packaged in a)30-count bottle (NDC 43598-322-30), b) 90-count bottle (NDC 43598-322-90), Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Bachupally, 500 090 India", "product_quantity": "", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20150506", "center_classification_date": "20150618", "termination_date": "20160331", "report_date": "20150624", "code_info": "Lot #: a) C401536, Exp 07/2015; b) C401538, Exp 07/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0718-2019", "product_description": "Dr. King's SafeCare Rx M3 Metabolic Mineral Modulator, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955027621, NDC 57955-0277-2", "product_quantity": "92 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 022216B Exp. 02/19; 062216S Exp. 06/19; 011217B Exp. 01/20"}, {"status": "Terminated", "city": "Hendersonville", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83997", "recalling_firm": "Basic Reset Inc.", "address_1": "260 W Main St Ste 103", "address_2": "N/A", "postal_code": "37075-7316", "voluntary_mandated": "FDA Mandated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and U.S. Virgin Islands, Canada, Nigeria, United Kingdom, Australia, Israel, Hungary, UAE, Mexico, Philippines, Greece", "recall_number": "D-0188-2020", "product_description": "Miracle Facelift Masque, All Natural, The Miracle in a Bottle, 2 fl. oz./60 mL bottle, Kim Kaufman Productions Nashville, TN.", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA", "recall_initiation_date": "20191018", "center_classification_date": "20191105", "termination_date": "20211027", "report_date": "20191113", "code_info": "ALL"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71846", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1355-2015", "product_description": "HEPARIN Sodium Injection USP, 12,500 USP Units added to 250 mL 5% Dextrose Injection USP (50 units per mL), packaged in 250 mL bags, Rx only, PharMEDium Services, LLC, 12620 W. Airport Blvd #130, Sugar Land, TX  77478, Service Code 2K0418, NDC# 61553-418-02.", "product_quantity": "480 bags", "reason_for_recall": "Presence of Particulate Matter: The firm produced products using 0.9% Sodium Chloride Injection, USP or 5% Dextrose Injection, USP which were subsequently recalled by the manufacturer due to the presence of particulate matter.", "recall_initiation_date": "20150413", "center_classification_date": "20150825", "termination_date": "20170123", "report_date": "20150902", "code_info": "Lot #: 15041123S, 15041003S, Exp 04/16/15"}, {"country": "United States", "city": "El Paso", "address_1": "1550 Northwestern Drive", "reason_for_recall": "Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.", "address_2": "", "product_quantity": "46,500 kits", "code_info": "All lots with expiry between 09/11 to 09/13.", "center_classification_date": "20130328", "distribution_pattern": "Nationwide, Puerto Rico, Virgin Islands, Malaysia, and United Kingdom", "state": "TX", "product_description": "Donor Prep Kit containing 1 FREPP (70% isopropyl alcohol), Net 1.1 mL and 1 SEPP (iodine tincture 2% USP), Net 0.67 mL per kit, packaged in 20-count kits per carton, Cat. No 260311, NDC 54365-201-99, CareFusion, Leawood, KS  66211.", "report_date": "20130403", "classification": "Class II", "openfda": {}, "recalling_firm": "CareFusion 213, LLC", "recall_number": "D-228-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64583", "termination_date": "20140512", "more_code_info": "", "recall_initiation_date": "20130304", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206763"], "brand_name": ["OLMESARTAN MEDOXOMIL"], "generic_name": ["OLMESARTAN MEDOXOMIL"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-445", "67877-446", "67877-447"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OLMESARTAN MEDOXOMIL"], "rxcui": ["349373", "349401", "349405"], "spl_id": ["a1d66aa9-d0fa-4d21-bba0-ff8078c2e5af"], "spl_set_id": ["142b735a-e1cd-46e1-a523-3ef061001bf9"], "package_ndc": ["67877-445-30", "67877-445-90", "67877-445-05", "67877-445-10", "67877-446-30", "67877-446-90", "67877-446-05", "67877-446-10", "67877-446-33", "67877-446-84", "67877-446-74", "67877-446-38", "67877-447-30", "67877-447-90", "67877-447-05", "67877-447-10"], "is_original_packager": [true], "upc": ["0367877445304"], "unii": ["6M97XTV3HD"]}, "product_type": "Drugs", "event_id": "84818", "recalling_firm": "Ascend Laboratories LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0828-2020", "product_description": "Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-446-90.", "product_quantity": "192 Bottles", "reason_for_recall": "cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement.", "recall_initiation_date": "20200124", "center_classification_date": "20200206", "termination_date": "20211029", "report_date": "20200212", "code_info": "Lot #: 19122552, Exp 7/31/2021"}, {"status": "Ongoing", "city": "Nogales", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96914", "recalling_firm": "Umary-USA.com", "address_1": "243 W Crawford St", "address_2": "STE 40026", "postal_code": "85621-3208", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Nationwide via internet.", "recall_number": "D-0492-2025", "product_description": "UNAVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7 503046 054295", "product_quantity": "1,342 30-count bottles", "reason_for_recall": "Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.", "recall_initiation_date": "20250521", "center_classification_date": "20250624", "report_date": "20250625", "code_info": "All Lots; All Expiration Dates.", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0765-2019", "product_description": "Dr. King's SafeCare Rx Yeast Freee..., 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955007623, NDC 57955-0102-2", "product_quantity": "537 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 081116A Exp. 08/19; 022417B Exp. 02/20"}, {"status": "Terminated", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71319", "recalling_firm": "Medtech Products, Inc.", "address_1": "660 White Plains Rd", "address_2": "N/A", "postal_code": "10591-5139", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1113-2015", "product_description": "SUCRETS Sore Throat & Cough Vapor Cherry lozenges, 18-count tin, Dist. By: Insight Pharmaceuticals, LLC, Trevose, PA  19053-8433", "product_quantity": "107,832 tins", "reason_for_recall": "Labeling: Label Mix-Up: An incorrect book label for Sucrets Sore Throat, Cough & Dry Mouth Honey Lemon lozenges was applied to the underside of the Sucrets Sore Throat & Cough Vapor Cherry lozenges tin.", "recall_initiation_date": "20150521", "center_classification_date": "20150601", "termination_date": "20180606", "report_date": "20150610", "code_info": "Lot #: 42451, Exp 09/17"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "100 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;    05112015@18, 8/9/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Phosphatidylcholine 0.1% Sodium Deoxycholate 0.089% Injection, Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1623-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "63 ml total", "code_info": "All lots distributed between November 2014 and May 2015;   05042015@50, 6/8/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "L-Arginine 100 mg/ml Injectable, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1561-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Peoria", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72241", "recalling_firm": "Kalman Health & Wellness, Inc. dba Essential Wellness Pharma", "address_1": "4625 N University St", "address_2": "N/A", "postal_code": "61614-5828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-320-2016", "product_description": "Progesterone 100 mg/mL IM* Injection in Sesame Oil, 10 mL vials, Rx only, Essential Wellness PHARMACY, 4625 N. University, Peoria, IL 61614.", "product_quantity": "50 vials", "reason_for_recall": "Lack of Assurance of Sterility:  A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.", "recall_initiation_date": "20150903", "center_classification_date": "20151117", "termination_date": "20171229", "report_date": "20151125", "code_info": "Lot #: 062315, Exp 09/23/2015; 071615, Exp 10/16/2015; and 080615, Exp 11/06/2015"}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Ste 100", "reason_for_recall": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules", "address_2": "", "product_quantity": "", "code_info": "Lots: 10029773 Exp. 11/17/2019,    10029821 Exp. 11/18/2019,    10030351 Exp. 11/21/2019,    10031014 Exp. 12/2/2019,  10030351 Exp. 11/21/2019,    10030912 Exp. 12/2/2019,  10030569 Exp. 11/28/2019,    10030966 Exp. 12/3/2019,    10031796 Exp. 12/23/2019,    10031509 Exp. 12/17/2019,    10031067 Exp. 12/5/2019,    10031156 Exp. 12/16/2019", "center_classification_date": "20191203", "distribution_pattern": "Nationwide.", "state": "TX", "product_description": "fentaNYL 2750 mcg/55 mL (50 mcg/mL) 55 mL Syringe, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478   NDC 70092-1100-50", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "QuVa Pharma, Inc.", "recall_number": "D-0558-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84263", "termination_date": "20200605", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83333", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "N/A", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S. and PR.", "recall_number": "D-1490-2019", "product_description": "Gatifloxacin Ophthalmic Solution 0.5%, For Use in the Eyes Only, Rx Only, Sterile, 2.5 mL Bottle, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC 68180-435-01.", "product_quantity": "17,238 bottles", "reason_for_recall": "Labeling: Missing label; Product complaints reported missing bottle label.", "recall_initiation_date": "20190711", "center_classification_date": "20190717", "termination_date": "20200909", "report_date": "20190724", "code_info": "Lot #: H805157, Exp. 05/2020"}, {"status": "Terminated", "city": "Tonawanda", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93154", "recalling_firm": "Pine Pharmaceuticals, LLC", "address_1": "355 Riverwalk Pkwy", "address_2": "N/A", "postal_code": "14150-5837", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0059-2024", "product_description": "Lidocaine-phenylephrine 1%-1.5% 1mL Single Dose Vial, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.", "product_quantity": "9673 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231002", "center_classification_date": "20231019", "termination_date": "20240515", "report_date": "20231025", "code_info": "Lot #: 67849, Exp. Date 10/25/2023; 67887, Exp. Date 10/28/2023; 68260, Exp. Date 11/14/2023; 68534, Exp. Date 11/27/2023; 68816, Exp. Date  12/12/2023; 69046, Exp. Date 12/20/2023; 69971, Exp. Date 1/13/2024"}, {"country": "United States", "city": "Phoenix", "address_1": "24416 N 19th Ave", "reason_for_recall": "Lack of Assurance of Sterility: Potential leakage of bags.", "address_2": "", "product_quantity": "225 syringes", "code_info": "Lot #: 5/10/18 1451 89561S, BUD 9/7/2018  .", "center_classification_date": "20180719", "distribution_pattern": "Nationwide in the USA", "state": "AZ", "product_description": "ePHEDrine Sulfate, USP 50 mg in 0.9% Sodium Chloride, USP QS 10mL.  50 mg/10 mL (5 mg per mL). Volume 10 mL Single dose syringe.  Avella of Houston, 9265 Kirby Dr., Houston, TX 77054 NDC 42852-895-61", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "recall_number": "D-0964-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80307", "termination_date": "20200124", "more_code_info": "", "recall_initiation_date": "20180612", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Berkeley Heights", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "97276", "recalling_firm": "Breckenridge Pharmaceutical, Inc.", "address_1": "200 Connell Dr Ste 4200", "address_2": "N/A", "postal_code": "07922-2805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S Nationwide", "recall_number": "D-0552-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 60mg, 1,000-count bottles, Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-748-10.", "product_quantity": "1,829 60-count bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above safety assessment limit", "recall_initiation_date": "20250715", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "Lot: 230836C, Exp.: 02/28/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206422"], "brand_name": ["FLUOCINOLONE ACETONIDE"], "generic_name": ["FLUOCINOLONE ACETONIDE"], "manufacturer_name": ["Lupin Pharmaceuticals,Inc."], "product_ndc": ["43386-069"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["FLUOCINOLONE ACETONIDE"], "rxcui": ["1191310"], "spl_id": ["15764733-88e0-40bf-ac92-ff4e3e35b15d"], "spl_set_id": ["460f5a55-6437-4651-bc08-8063ca579c8d"], "package_ndc": ["43386-069-60"], "is_original_packager": [true], "upc": ["0343386069606"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["0CD5FD6S2M"]}, "product_type": "Drugs", "event_id": "81168", "recalling_firm": "LUPIN SOMERSET", "address_1": "400 Campus Dr", "address_2": "N/A", "postal_code": "08873-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0092-2019", "product_description": "Fluocinolone Acetonide Topical Solution, USP 0.01%, 60ml Bottle, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, MD 21202 Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. NDC  43386-069-60", "product_quantity": "2712 60-ml bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:Out of specification result noticed for total impurities observed during stability analysis", "recall_initiation_date": "20181005", "center_classification_date": "20181024", "termination_date": "20221108", "report_date": "20181031", "code_info": "Lot# M16666, EXP 12/2018"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0535-2017", "product_description": "CLOBETASOL 0.05% IN OLEA BASE, CLOBETASOL 0.05% IN OROBASE, CLOBETASOL 0.05% OINTMENT, CLOBETASOL 0.05%/ SODIUM, SULFACETAMIDE 10% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1030-2017", "product_description": "PHENYLephrine 20 mg in 0.9% Sodium Chloride 250 mL Bag, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0816-40", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lot: 20170503@19 BUD: 8/1/2017"}, {"status": "Terminated", "city": "Spokane", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83253", "recalling_firm": "First Pharma Associates LLC dba Riverpoint Pharmacy", "address_1": "1802 N Monroe St", "address_2": "", "postal_code": "99205-4528", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "ID, WA only", "recall_number": "D-1475-2019", "product_description": "Prostaglandin 20 mcg/mL/Procaine 0.1% Injection, packaged in a) 2.5mL and b)10 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205 (509) 343-6252", "product_quantity": "a) 2.5 mL b) 10 mL", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20190626", "center_classification_date": "20190711", "termination_date": "20230606", "report_date": "20190717", "code_info": "Lot #: a) 06182019@16, Exp. 08/04/2019  b) 06032019@8, Exp. 07/18/2019", "more_code_info": ""}, {"status": "Terminated", "city": "North Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "71973", "recalling_firm": "Ohm Laboratories, Inc.", "address_1": "1385 Livingston Ave", "address_2": "N/A", "postal_code": "08902-1829", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0034-2016", "product_description": "Safeway Care Loratadine Orally Disintegrating Tablets, USP, 10 mg, packaged in a) 10-count tablets per box (NDC 21130-527-69, UPC 3 2113076240 9); b)  30-count tablets per box (NDC 21130-527-31, UPC 3 2113076252 2) Distributed by Safeway Inc. PO BOX 99, Pleasanton, CA  94566", "product_quantity": "33,984 boxes", "reason_for_recall": "Superpotent Drug: Out Of Specification (OOS) result for Assay.", "recall_initiation_date": "20150728", "center_classification_date": "20151015", "termination_date": "20161028", "report_date": "20151021", "code_info": "Batch Numbers:    a) 2658140, Exp 11/30/2016;  2625092, Exp  6/30/2016; 2617893, Exp 5/31/2016; b) 2625092, Exp  6/30/2016; 2617893, Exp 5/31/2016; 2644265, Exp 9/30/2016"}, {"country": "United States", "city": "Lake Forest", "address_1": "275 N Field Dr", "reason_for_recall": "Presence of Particulate Matter: Confirmed customer complaint of particulate matter, identified as a human hair, visible in the injection port and primary container.", "address_2": "", "product_quantity": "17,256 containers", "code_info": "Lot#  26-138-JT; Exp. 08/14", "center_classification_date": "20140113", "distribution_pattern": "Nationwide", "state": "IL", "product_description": "Aminosyn II, 10%, Sulfite-Free Amino Acid Injection, 500 mL container, Rx only, Hospira, Inc., Lake Forest, IL  60045, NDC 0409-4164-03, UPC (01) 0 030409 416403 8.", "report_date": "20140122", "classification": "Class I", "openfda": {}, "recalling_firm": "Hospira Inc.", "recall_number": "D-461-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66147", "termination_date": "20150821", "more_code_info": "", "recall_initiation_date": "20130830", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91672", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0910-2023", "product_description": "allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 11673-617-22), b)30-count cartons (NDC 11673-617-39), c)70-count cartons (NDC 11673-617-01), and d)150-count cartons (11673-617-47), Distributed by: Target Corporation, Minneapolis, MN 55403.", "product_quantity": "208,416 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230209", "center_classification_date": "20230711", "termination_date": "20230911", "report_date": "20230719", "code_info": "Lot #: a) 2HE2032, 2JE1882, 2JE2185 Exp. Date 01/24; b) 2DR0464, 2ER0410, Exp. Date 12/23; 2ER0286, 2ER0411, Exp. Date 01/24 c)  2DR0467, 2DR0468, 2DR0469, 2ER0288, Exp. Date 12/23 d) 2ER0414, Exp. Date 01/24, 2GR0333, Exp. Date 02/24", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0210-2020", "product_description": "S-DEXTROSE/GLYCERIN/PHENOL 25/25/2.5% INJ SOLN, 30 ml glass vial, Rx Only, Red Mountain Compounding Rx", "product_quantity": "8x30 ml glass vial", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #: S07292019DH@13, Exp 8/29/19"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212971"], "brand_name": ["TOPCARE ALLERGY RELIEF"], "generic_name": ["FEXOFENADINE HYDROCHLORIDE"], "manufacturer_name": ["Topco Associates LLC"], "product_ndc": ["36800-691"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE"], "rxcui": ["997420"], "spl_id": ["51cf462b-21b6-44e2-b97a-da14622f3947"], "spl_set_id": ["e7658b5f-2d78-4f25-b1a3-e49198ca8f32"], "package_ndc": ["36800-691-13", "36800-691-39", "36800-691-22", "36800-691-49", "36800-691-95", "36800-691-75"], "is_original_packager": [true], "unii": ["2S068B75ZU"]}, "product_type": "Drugs", "event_id": "91672", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0912-2023", "product_description": "Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 36800-691-39), b)45-count cartons (NDC  36800-691-95), and 90-count cartons (NDC 36800-691-75), Distributed by: Topco Associates LLC, Elk Grove Village, IL 60007.", "product_quantity": "44,280 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230209", "center_classification_date": "20230711", "termination_date": "20230911", "report_date": "20230719", "code_info": "Lot #: a) 2FV1948, 2ER0285, 2ER0411, Exp. Date 01/24 b)2CR0653, Exp. Date 12/23 c)2GR0331, Exp. Date 04/24", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0126-2015", "product_description": "Quad mix, 18 mg/0.2 mg/10 mcg/0.02 mg/mL (papaverine, phentolamine mesylate, alprostadil, atropine) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "10 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 07302014@29, Exp 10/28/2014; 08192014@31, Exp 11/17/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Sterling", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91443", "recalling_firm": "Northern VA Compounders PLLC", "address_1": "23475 Rock Haven Way", "address_2": "Suite 105", "postal_code": "20166-4444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0115-2023", "product_description": "TriMix Injection (PGE1/Papaverine HCl/Phentolamine Mesylate) 60mcg/30mg/3mg/mL INJECTABLE, 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA  20166.", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20221230", "center_classification_date": "20230112", "termination_date": "20230621", "report_date": "20230118", "code_info": "Lot#: 11182022@2, Exp 1/2/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91952", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0511-2023", "product_description": "Atorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7630-9", "product_quantity": "158 Bottles", "reason_for_recall": "cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.", "recall_initiation_date": "20230323", "center_classification_date": "20230406", "report_date": "20230412", "code_info": "Lot #: A0523D, Exp 5/31/2024, F14220, Exp 7/31/2023, J0622Q; Exp 1/31/2024.", "more_code_info": ""}, {"status": "Ongoing", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81646", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide including Puerto Rico.", "recall_number": "D-0305-2019", "product_description": "Amlodipine and Valsartan Tablets 5 mg/320 mg, (a) 30-count bottles (NDC 0093-7692-56) & 90-count bottles (NDC 0093-7692-98), RX Only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel, Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.", "product_quantity": "75,883 bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.", "recall_initiation_date": "20181127", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "NDC 0093-7692-56 & NDC 0093-7692-98  Lot # 25X028, 25X029, 25X030, 25X031, 25X032, 25X035, 25X037"}, {"status": "Terminated", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA201695"], "brand_name": ["FAMOTIDINE"], "generic_name": ["FAMOTIDINE"], "manufacturer_name": ["Lupin Pharmaceuticals,Inc."], "product_ndc": ["43386-500"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FAMOTIDINE"], "rxcui": ["310274"], "spl_id": ["82462011-668a-4fbd-9653-48049901eacc"], "spl_set_id": ["a0bdf4d1-8458-4e4f-95aa-bcc38c0f32f8"], "package_ndc": ["43386-500-11"], "is_original_packager": [true], "upc": ["0343386500116"], "nui": ["N0000000151", "N0000175784"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "unii": ["5QZO15J2Z8"]}, "product_type": "Drugs", "event_id": "68722", "recalling_firm": "Novel Laboratories, Inc.", "address_1": "400 Campus Dr", "address_2": "N/A", "postal_code": "08873-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1484-2014", "product_description": "Famotidine for Oral Suspension, USP 40 mg/5 mL, Rx Only, Cherry-Banana-Mint Flavored, Not for Injection, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873.  Distributed by: Gavis Pharmaceuticals, LLC, Somerset, NJ 08873, NDC 43386-500-11.", "product_quantity": "25,776 containers", "reason_for_recall": "Failed Impurity/Degradation Specification; 12-month stability time point", "recall_initiation_date": "20140620", "center_classification_date": "20140822", "termination_date": "20150629", "report_date": "20140903", "code_info": "Lot #'s M13075A, M13076A, M13076B, M13077A, M13077B all with expiry dated 2/2015 and M13490A with expiry date 3/2016."}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA062702"], "brand_name": ["CEPHALEXIN"], "generic_name": ["CEPHALEXIN"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-3145", "0093-3147", "0093-4175", "0093-4177"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEPHALEXIN"], "rxcui": ["309110", "309112", "309113", "309114"], "spl_id": ["c75c0bb6-fe3e-43c6-bdde-edd904731795"], "spl_set_id": ["19307ff0-71de-477b-965d-ea243e5ede3a"], "package_ndc": ["0093-3145-01", "0093-3145-05", "0093-3147-01", "0093-3147-05", "0093-4175-73", "0093-4175-74", "0093-4177-73", "0093-4177-74"], "is_original_packager": [true], "upc": ["0300934175738", "0300934177732"], "unii": ["OBN7UDS42Y"]}, "product_type": "Drugs", "event_id": "86285", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S. and Puerto Rico.", "recall_number": "D-0013-2021", "product_description": "Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle when mixed, NDC 0093-4177-73, b) 200 mL bottle when mixed, NDC 0093-4177-74, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.", "product_quantity": "1,467,535 bottles", "reason_for_recall": "CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.", "recall_initiation_date": "20200824", "center_classification_date": "20201002", "termination_date": "20211216", "report_date": "20200916", "code_info": "Lot #s:  a) 30309862A, 30309863A, Exp. 08/2020; 30309928A, 30309929A, Exp. 09/2020; 30310029A, 30310030A, 30310033A, 30310034A, Exp. 10/2020; 30310035A, 30310079A, 30310080A, 30310081A, Exp. 11/2020; 30310134A,   30310135A, Exp. 01/2021; 30310182A, 30310183A, 30310210A,  Exp. 02/2021; 30310211A, 30310246A, Exp. 03/2021; 30310282A, Exp. 04/2021; 30310290A, Exp. 05/2021; 30310394A, 30310395A, Exp.07/2021; 30310457A, Exp. 09/2021; 30310506A, 30310507A, Exp. 10/2021; 30310555A, 30310605A, Exp. 11/2021.  b) 30309864A, 30309865A, Exp. 08/2020; 30309930A, 30309931A, Exp. 09/2020; 30309991A, 30309992A, 30310028A, Exp.10/2020; 30310036A, 30310037A, 30310038A, Exp. 11/2020; 30310082A, 30310083A, Exp. 12/2020;   30310136A, 30310137A, Exp. 01/2021; 30310184A, 30310185A, Exp. 02/2021;  30310212A, Exp. 03/2021; 30310303A, Exp. 04/2021; 30310327A, Exp. 06/2021; 30310396A, 30310407A, Exp. 08/2021; 30310445A, Exp. 09/2021; 30310556A, Exp. 10/2021.", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "33 units", "code_info": "Rx #'s:  0397555    0397557    0382534        0400837        0407829    0390562          0390562        0395167    0397757    0396775    0394599    0390562          0396775    0390562    0390562    0396775    0389984    0387701    0389984", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "EPINEPHRINE **(25X1ML AMPULS) 1:1000 1MG/ML INJECTABLE 25 ML;  EPINEPHRINE HCL SOLUTION 1% OPHTHALMIC 10 ML, 20 ML; EPIINEPHRINE P.F. (SULFITE-FREE) 1:1,000 (1MG/ML) INJECTABLE 1 ML, 2 ML, 20 ML, 25 ML, 3 ML, 30 ML, 4 ML, 5 ML, 50 ML; EPINEPHRINE PF IN BSS, OPHTHALMIC (CONTAINS SULFITES) 1:1000 (1MG/ML) INJECTABLE\t15 ML, 16 ML, 30 ML (15 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1514-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206745"], "brand_name": ["ENTECAVIR"], "generic_name": ["ENTECAVIR"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-920", "68382-921"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ENTECAVIR"], "rxcui": ["485434", "485436"], "spl_id": ["b9646f09-8d5b-4271-b2b1-b1d66a91ed73"], "spl_set_id": ["b4fd0e22-ad23-4f51-9b98-95182f63c2eb"], "package_ndc": ["68382-920-06", "68382-920-16", "68382-920-01", "68382-920-30", "68382-920-77", "68382-921-06", "68382-921-16", "68382-921-01", "68382-921-30", "68382-921-77"], "is_original_packager": [true], "unii": ["5968Y6H45M"]}, "product_type": "Drugs", "event_id": "97556", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0657-2025", "product_description": "Entecavir Tablets, USP, 1 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.", "product_quantity": "4440 bottles", "reason_for_recall": "Failed Impurity/Degradation Specifications", "recall_initiation_date": "20250904", "center_classification_date": "20250918", "report_date": "20250924", "code_info": "Lot E309377, Exp 11/30/2025"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "130 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  03092015@26, 6/7/2015; 03122015@95, 6/10/2015; 04132015@5, 6/12/2015; 04292015@8, 6/28/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Hydromorphone 20 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1547-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210965"], "brand_name": ["PROGESTERONE"], "generic_name": ["PROGESTERONE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-306"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["PROGESTERONE"], "rxcui": ["312644"], "spl_id": ["44ca9ab1-7336-4914-b059-79559747ac39"], "spl_set_id": ["7d19df3b-94ed-4681-beae-9caaf137d014"], "package_ndc": ["55150-306-10"], "is_original_packager": [true], "nui": ["M0017672", "N0000175601"], "pharm_class_cs": ["Progesterone [CS]"], "pharm_class_epc": ["Progesterone [EPC]"], "unii": ["4G7DS2Q64Y"]}, "product_type": "Drugs", "event_id": "95059", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0624-2024", "product_description": "Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E Windsor, NJ 08520, NDC 55150-306-10.", "product_quantity": "17136 vials", "reason_for_recall": "Presence of Particulate Matter: Complaint received of a glass particle in the vial.", "recall_initiation_date": "20240726", "center_classification_date": "20240801", "report_date": "20240807", "code_info": "Lot #: CPR230029A"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx # 28300, Exp 02/7/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Ambisome 285 mg/250 mL D5W, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 28300, Discard After 02/7/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1469-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Columbus", "address_1": "2550 John Glenn Ave Ste A", "reason_for_recall": "Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule", "address_2": "", "product_quantity": "867 cartons", "code_info": "Lot 162276, exp. 9/30/17", "center_classification_date": "20160902", "distribution_pattern": "Product was distributed in the following states: Nationwide", "state": "OH", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product) CII 20 mg, 30 UD Tablets (5 x 6), Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH ---   Carton NDC 68084-943-25; Blister NDC 68084-943-95", "report_date": "20160914", "classification": "Class II", "openfda": {}, "recalling_firm": "Amerisource Health Services", "recall_number": "D-1484-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "75076", "termination_date": "20171218", "more_code_info": "", "recall_initiation_date": "20160824", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Glasgow", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078476"], "brand_name": ["FOSPHENYTOIN SODIUM"], "generic_name": ["FOSPHENYTOIN"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["70121-1381", "70121-1390"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["FOSPHENYTOIN SODIUM"], "rxcui": ["1670195", "1670200"], "spl_id": ["bd30ea3a-8a0f-407a-8664-d61fd4711ed0"], "spl_set_id": ["39b58213-b9e2-4847-9010-99e187c1b778"], "package_ndc": ["70121-1390-1", "70121-1390-7", "70121-1381-1", "70121-1381-5"], "is_original_packager": [true], "upc": ["0370121139072", "0370121138150"], "unii": ["7VLR55452Z"]}, "product_type": "Drugs", "event_id": "78035", "recalling_firm": "Amneal Pharmaceuticals LLC", "address_1": "118 Beaver Trl", "address_2": "N/A", "postal_code": "42141-1273", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, NC, OH, TX, UT", "recall_number": "D-0076-2018", "product_description": "Fosphenytoin Sodium Injection, USP,  500 mg  PE/10 mL (50 mg PE/mL.  10 mL Single Dose Vial, Rx Only. Distributed by: Amneal Biosciences, Bridgewater, NJ 08807. NDC: 70121-1390-7", "product_quantity": "14,000 vials", "reason_for_recall": "Presence of Particulate Matter", "recall_initiation_date": "20170831", "center_classification_date": "20171113", "termination_date": "20190910", "report_date": "20171122", "code_info": "Lot # AP160016; Exp. 05/18"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0384-2020", "product_description": "CVS Health Overnight Lubricating Eye Ointment, Sterile, Net wt. 0.125 oz. (3.5g), Item #881532, Distributed by: CVS Pharmacy Inc., One CVS Drive, Woonsocket, RI 02895", "product_quantity": "284,232 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: RJK 10/19  SBJ 2/20  SFG 6/20  SHI 8/20  SLB 12/20  TCM 03/21  TDC 4/21"}, {"status": "Terminated", "city": "Statesville", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89773", "recalling_firm": "Family Pharmacy of Statesville", "address_1": "3478 E Broad St", "address_2": "N/A", "postal_code": "28625-4523", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "NC only", "recall_number": "D-0665-2022", "product_description": "Lorazepam 1 mg/mL Infusion Solution in 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc.", "product_quantity": "1 bag", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200806", "center_classification_date": "20220317", "termination_date": "20230815", "report_date": "20220323", "code_info": "Lot #: 07312020@6 BUD: 8/7/2020"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0471-2020", "product_description": "TRP Pink Eye Relief, 10 mL, NDC 17312-013-15", "product_quantity": "1,381,638 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17185 6/20  17228 7/20  17349 11/20  18073 3/21  18218 8/21  18303 12/21"}, {"status": "Terminated", "city": "Zebulon", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62392", "recalling_firm": "GlaxoSmithKline Inc", "address_1": "1011 North Arendell Ave", "address_2": "P.O. Box 1217", "postal_code": "27597-1217", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1412-2012", "product_description": "Trizivir (abacavir sulfate 300mg, lamivudine 150 mg and zidovudine 300 mg), 60 Tablets, Rx only, Manufactured for: ViiV Healthcare, Research Triangle Park, NC 27709 by: GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 49702-217-18", "product_quantity": "14,465 bottles", "reason_for_recall": "Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets.", "recall_initiation_date": "20120604", "center_classification_date": "20120712", "termination_date": "20140904", "report_date": "20120718", "code_info": "Lot #0ZP5128 exp; 8/2013", "more_code_info": ""}]